Research Article
Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris
Table 4
Secondary endpoints in patients with UAP in the β-blocker and no β-blocker groups.
| | Before PS match | After PS match | β-Blocker (-) N = 1801 | β-Blocker (+) N = 3790 | value | β-Blocker (-) N = 1786 | β-Blocker (+) N = 1786 | value |
| Event | All-cause death or heart failure | No. of patients | 68 | 214 | | 67 | 99 | | Event rate (%) | 3.8 | 5.6 | 0.003 | 3.8 | 5.5 | 0.011 | Unadjusted HR (95% CI) | 1.00 | 1.41 (1.07, 1.85) | 0.013 | 1.00 | 1.40 (1.03, 1.91) | 0.033 | Adjusted HR (95% CI) | 1.00 | 1.16 (0.88,1.53) | 0.296 | 1.00 | 1.20 (0.88, 1.65) | 0.256 |
| All-cause death, heart failure, or nonfatal MI | No. of patients | 94 | 272 | | 93 | 128 | | Event rate (%) | 5.2 | 7.2 | 0.006 | 5.2 | 7.2 | 0.015 | Unadjusted HR (95% CI) | 1.00 | 1.30 (1.03, 1.65) | 0.027 | 1.00 | 1.31 (1.01, 1.71) | 0.046 | Adjusted HR (95% CI) | 1.00 | 1.08 (0.85, 1.38) | 0.520 | 1.00 | 1.17 (0.89,1.53) | 0.267 |
| All-cause death, heart failure, nonfatal MI, or nonfatal stroke | No. of patients | 108 | 305 | | 107 | 141 | | Event rate (%) | 6.0 | 8.0 | 0.006 | 6.0 | 7.9 | 0.025 | Unadjusted HR (95% CI) | 1.00 | 1.27 (1.02, 1.58) | 0.035 | 1.00 | 1.25 (0.97, 1.61) | 0.082 | Adjusted HR (95% CI) | 1.00 | 1.04 (0.83, 1.31) | 0.712 | 1.00 | 1.11 (0.86, 1.44) | 0.410 |
|
|
Data are presented as number or HR (95% CI). MI, myocardial infarction.
|